1
项与 Anti-CD19 CAR-T cell therapy(The First Affiliated Hospital of Nanchang University) 相关的临床试验Study Evaluating the Safety and Efficacy With Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas
This is a single arm, open-label, single center study to determine the safety and efficacy of Anti-CD19 CAR-T cells in patients with relapsed or refractory acute lymphoblastic leukemia and Lymphomas.
100 项与 Anti-CD19 CAR-T cell therapy(The First Affiliated Hospital of Nanchang University) 相关的临床结果
100 项与 Anti-CD19 CAR-T cell therapy(The First Affiliated Hospital of Nanchang University) 相关的转化医学
100 项与 Anti-CD19 CAR-T cell therapy(The First Affiliated Hospital of Nanchang University) 相关的专利(医药)
100 项与 Anti-CD19 CAR-T cell therapy(The First Affiliated Hospital of Nanchang University) 相关的药物交易